Serum KL-6 level as a biomarker of interstitial lung disease in childhood connective tissue diseases: a pilot study
- PMID: 31784789
- DOI: 10.1007/s00296-019-04485-4
Serum KL-6 level as a biomarker of interstitial lung disease in childhood connective tissue diseases: a pilot study
Abstract
Krebs von den Lungen-6 (KL-6) has been described as a promising biomarker in the diagnosis and determining the severity of interstitial lung disease in adults with connective tissue disease. This study was performed to determine whether the serum KL-6 level is useful as a biomarker for detecting the interstitial lung disease (ILD) in pediatric cases of connective tissue disease (CTD). In total, 88 patients [36 patients with systemic juvenile idiopathic arthritis (sJIA), 27 patients with juvenile systemic lupus erythematosus (JSLE), 14 patients with juvenile dermatomyositis (JDM), and 11 patients with juvenile systemic sclerosis (JSSc)] and 68 healthy controls were included in this study. Age, sex, and duration of CTD and ILD (if any) were recorded. Blood samples from all the patients and controls were examined by ELISA. Eleven of the 88 patients with CTD (12.5%) had ILD and all of them were symptomatic. Subgroup analysis indicated that eight patients had JSSc, two had JSLE, and one had systemic JIA. The median serum KL-6 level was 1450.5 U/mL (interquartile range (IQR) 742.9-2603.2) in the CTD with ILD group, 415.9 U/mL (IQR 233.4-748.4) in the CTD without ILD group, and 465.9 U/mL (IQR 273.6-1036) in the control group. KL-6 levels were significantly higher in the CTD with ILD group than the CTD without ILD group and the control group (p = 0.003). At a cut-off of 712.5 U/ml identified by ROC curve, serum KL-6 yielded a sensitivity of 81% and specificity of 72% for CTD with ILD group. There was no significant difference in serum KL-6 level among the disease subgroups (sJIA, JSLE, JSSc, JDM), in either the CTD with ILD group or the CTD without ILD group (p > 0.05). In conclusion, KL-6 is a useful biomarker of CTD with ILD in pediatric patients.
Keywords: Connective tissue diseases; Interstitial lung diseases; Juvenile idiopathic arthritis; KL-6; Systemic lupus erythematosus; Systemic sclerosis.
Similar articles
-
Comparative diagnostic efficacy of serum Krebs von den Lungen-6 and surfactant D for connective tissue disease-associated interstitial lung diseases: A meta-analysis.Medicine (Baltimore). 2020 Apr;99(16):e19695. doi: 10.1097/MD.0000000000019695. Medicine (Baltimore). 2020. PMID: 32311947 Free PMC article.
-
Serum KL-6 as predictive and prognostic marker of interstitial lung disease in childhood connective tissue diseases: a pilot study.Reumatismo. 2021 Nov 22;73(3). doi: 10.4081/reumatismo.2021.1399. Reumatismo. 2021. PMID: 34814656
-
Association of serum KL-6 levels with interstitial lung disease in patients with connective tissue disease: a cross-sectional study.Clin Rheumatol. 2016 Mar;35(3):663-6. doi: 10.1007/s10067-015-3167-8. Epub 2016 Jan 13. Clin Rheumatol. 2016. PMID: 26758437
-
The clinical value of KL-6 for predicting the occurrence and severity of connective tissue disease-associated interstitial lung disease is not affected by CTD type or treatment.PeerJ. 2024 Aug 8;12:e17792. doi: 10.7717/peerj.17792. eCollection 2024. PeerJ. 2024. PMID: 39131623 Free PMC article.
-
Serum KL-6 and the mortality of patients with connective tissue disease-associated interstitial lung disease: A meta-analysis.Biomol Biomed. 2024 Sep 6;24(5):1105-1116. doi: 10.17305/bb.2024.10368. Biomol Biomed. 2024. PMID: 38743787 Free PMC article.
Cited by
-
Serologic phenotypes distinguish systemic lupus erythematosus patients developing interstitial lung disease and/or myositis.Lupus. 2022 Oct;31(12):1477-1484. doi: 10.1177/09612033221122158. Epub 2022 Aug 26. Lupus. 2022. PMID: 36018314 Free PMC article.
-
The value of KL-6 in the diagnosis and assessment of interstitial lung disease.Am J Transl Res. 2021 Aug 15;13(8):9216-9223. eCollection 2021. Am J Transl Res. 2021. PMID: 34540037 Free PMC article.
-
Undercover lung damage in pediatrics - a hot spot in morbidity caused by collagenoses.Front Immunol. 2024 Jun 27;15:1394690. doi: 10.3389/fimmu.2024.1394690. eCollection 2024. Front Immunol. 2024. PMID: 38994372 Free PMC article. Review.
-
Ocular sarcoidosis in adults and children: update on clinical manifestation and diagnosis.J Ophthalmic Inflamm Infect. 2023 Sep 18;13(1):41. doi: 10.1186/s12348-023-00364-z. J Ophthalmic Inflamm Infect. 2023. PMID: 37721575 Free PMC article. Review.
-
Comparative diagnostic efficacy of serum Krebs von den Lungen-6 and surfactant D for connective tissue disease-associated interstitial lung diseases: A meta-analysis.Medicine (Baltimore). 2020 Apr;99(16):e19695. doi: 10.1097/MD.0000000000019695. Medicine (Baltimore). 2020. PMID: 32311947 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous